Login / Signup

Effect of high nucleated cell concentration on product viability and hematopoietic recovery in autologous transplantation.

David Ming-Hung LinMatthew HiskeyJane HuangCherie NickersonDesmond SaisitthidejAndrea BradfordJoshua WoodburnAndrea LiusAdam SkrzekutEllen TranRebecca Haley
Published in: Transfusion (2020)
Our retrospective investigation provides further supporting evidence that HPC(A) products with cell concentration greater than 3 × 108 NC/mL did not show detrimental effects on the clinical outcomes in patients undergoing autologous PBSC transplantation.
Keyphrases
  • cell therapy
  • patients undergoing
  • bone marrow
  • single cell
  • stem cells
  • mesenchymal stem cells
  • platelet rich plasma